Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome

被引:152
作者
Diamanti-Kandarakis, E
Piperi, C
Kalofoutis, A
Creatsas, G
机构
[1] Univ Athens, Sch Med, Dept Internal Med 1, Endocrine Sect, Athens, Greece
[2] Univ Athens, Sch Med, Aretaie Hosp, Dept Obstet & Gynaecol 2, Athens, Greece
[3] Univ Athens, Sch Med, Biol Chem Lab, Athens, Greece
关键词
D O I
10.1111/j.1365-2265.2004.02170.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Women with polycystic ovary syndrome (PCOS) carry a number of cardiovascular risk factors and are considered to be at increased risk for atherosclerosis. Elevated concentrations of advanced glycation end-products (AGE), which exert their effects through interaction with specific receptors (RAGE), have been implicated in the cellular and tissue damage during atherosclerotic processes. Design/patients We investigated serum AGE levels in 29 young women with PCOS as well as the expression of their receptor, RAGE, in circulating monocytes and compared them levels with 22 healthy control women. Measurements/results Women with PCOS had higher levels of serum AGE proteins compared to healthy individuals (9.81 +/- 0.16 vs. 5.11 +/- 0.16, P < 0.0001), and increased RAGE expression was observed in monocytes of PCOS women compared to controls (30.91 +/- 10.11 vs. 7.97 +/- 2.61, P < 0.02). A positive correlation was observed between AGE proteins and testosterone (T) levels (r = 0.73, P < 0.0001). The correlation between AGE proteins and T levels remained high (partial correlation coefficient = 0.61, P = 0.0001) after controlling for body mass index (BMI), insulin levels and the area under the curve for glucose (AUCGLU) during an oral glucose tolerance test (OGTT). A positive correlation was also observed between AGE proteins and the free androgen index (FAI) (r = 0.58, P < 0.0001), waist-to-hip ratio (WHR) (r = 0.31, P < 0.02), insulin (r = 0.46, P < 0.001), homeostasis model assessment (HOMA) (r = 0.47, P < 0.0001), AUCGLU (r = 0.52, P < 0.002) and RAGE (r = 0.59, P < 0.01). A negative correlation was observed between AGE proteins and glucose/insulin ratio (GLU/INS) (r = -0.35, P < 0.01), and the quantitative insulin sensitivity check index (QUICKI) (r =-0.50, P < 0.01). In multiple regression analysis T was the only independent predictor of AGE levels (P < 0.0001, b = 0.044) between BMI, insulin, SHBG and AUCGLU (adjusted R-2 = 0.59, F = 44.41, P < 0.0001). Conclusion These data clearly demonstrate, for the first time, that PCOS women without overt hyperglycaemia have increased AGE levels and elevated RAGE expression when compared with controls.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 37 条
[1]   MACROPHAGE SCAVENGER RECEPTOR MEDIATES THE ENDOCYTIC UPTAKE AND DEGRADATION OF ADVANCED GLYCATION END-PRODUCTS OF THE MAILLARD REACTION [J].
ARAKI, N ;
HIGASHI, T ;
MORI, T ;
SHIBAYAMA, R ;
KAWABE, Y ;
KODAMA, T ;
TAKAHASHI, K ;
SHICHIRI, M ;
HORIUCHI, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (02) :408-415
[2]   Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization [J].
Birdsall, MA ;
Farquhar, CM ;
White, HD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) :32-35
[3]   RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN LEAN AND OBESE WOMEN WITH THE POLYCYSTIC-OVARY-SYNDROME [J].
CONWAY, GS ;
AGRAWAL, R ;
BETTERIDGE, DJ ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1992, 37 (02) :119-125
[4]   POLYCYSTIC-OVARY-SYNDROME AND RISK FOR MYOCARDIAL-INFARCTION - EVALUATED FROM A RISK FACTOR MODEL BASED ON A PROSPECTIVE POPULATION STUDY OF WOMEN [J].
DAHLGREN, E ;
JANSON, PO ;
JOHANSSON, S ;
LAPIDUS, L ;
ODEN, A .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (08) :599-604
[5]   The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels [J].
Diamanti-Kandarakis, E ;
Palioniko, G ;
Alexandraki, K ;
Bergiele, A ;
Koutsouba, T ;
Bartzis, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (06) :793-798
[6]   A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[7]   Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy [J].
Diamanti-Kandarakis, E ;
Spina, G ;
Kouli, C ;
Migdalis, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4666-4673
[8]   New perspectives in polycystic ovary syndrome [J].
DiamantiKandarakis, E ;
Dunaif, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1996, 7 (08) :267-271
[9]   EXCESSIVE INSULIN-RECEPTOR SERINE PHOSPHORYLATION IN CULTURED FIBROBLASTS AND IN SKELETAL-MUSCLE - A POTENTIAL MECHANISM FOR INSULIN-RESISTANCE IN THE POLYCYSTIC-OVARY-SYNDROME [J].
DUNAIF, A ;
XIA, JR ;
BOOK, CB ;
SCHENKER, E ;
TANG, ZC .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :801-810
[10]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174